Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies

被引:19
|
作者
Gottsäter, A [1 ]
Forsblad, J
Mätzsch, T
Persson, K
Ljungcrantz, I
Ohlsson, K
Lindgärde, F
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Clin Microbiol, Malmo, Sweden
[3] Lund Univ, Malmo Univ Hosp, Dept Surg Pathophysiol, Malmo, Sweden
关键词
carotid artery stenosis; Chlamydia pneumoniae; interleukin-1 receptor antagonist; interleukin-1; beta; triglycerides;
D O I
10.1046/j.1365-2796.2002.00926.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate whether the interleukin-1 receptor antagonist (Il-1ra) and interleukin-1beta (Il-1beta) can be detected in human carotid artery tissue, and whether their presence is related to evidence of Chlamydia pneumoniae infection, risk factors for atherosclerosis, and clinical data. Setting. Departments of Vascular Diseases and Surgical Pathophysiology, University Hospital, Malmo, Sweden. Subjects. A total of 66 patients undergoing carotid endarterectomy (median age 74, range 53-89 years, 20 women). Il-1beta and Il-1ra were studied in carotid artery plaques and in Il-1ra in serum. Results. Interleukin-1 receptor antagonist was detected in mononuclear cells in plaques from 37/ 66 (56%) patients. Patients with Il-1ra in plaques showed higher [2.04 (1.70-3.14) mmol L-1 vs. 1.69 (1.09-1.99) mmol L-1; P < 0.05] serum(s-)triglyceride(tg) levels, and a higher frequency of IgA seropositivity for C. pneumoniae (76% vs. 52%: P < 0.05) than those without. S-Il-1ra levels correlated with s-tg levels (r = 0.38; P = 0.047). There were no differences between patients with and without Il-1ra in plaques concerning s-Il-1ra, blood(b-)haemoglobin or leucocyte count, s-cholesterol, b-glucose, blood pressure, IgG seropositivity for C. pneumoniae, prevalence of neurological symptoms preceding operation, smoking, or diabetes mellitus. There were no differences in frequency of Il-1ra in plaques or in s-Il-1ra levels between patients with symptomatic and asymptomatic stenosis, between smokers and nonsmokers, or between diabetic and nondiabetic patients. Il-1beta was not detected in plaques in the current study. Conclusion. Interleukin-1 receptor antagonist can be detected in human atherosclerotic carotid artery plaques, and is related to s-triglyceride levels and IgA seropositivity for C. pneumoniae, but not to prevalence of neurological symptoms related to embolization.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [41] Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
    Hui, Queenie
    Asadi, Ali
    Park, Yoo Jin
    Kieffer, Timothy J.
    Ao, Ziliang
    Warnock, Garth L.
    Marzban, Lucy
    MOLECULAR METABOLISM, 2017, 6 (08): : 833 - 844
  • [42] Activin a regulates the production of mature interleukin-1β and interleukin-1 receptor antagonist in human monocytic cells
    Ohguchi, M
    Yamato, K
    Ishihara, Y
    Koide, M
    Ueda, N
    Okahashi, N
    Noguchi, T
    Kizaki, M
    Ikeda, Y
    Sugino, H
    Nisihara, T
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (07): : 491 - 498
  • [43] Interleukin-1 and interleukin 1 receptor antagonist levels at healthy and diseased implant sites.
    Weenig, DR
    Guthmiller, JM
    Organ, CC
    Wolf, K
    Dawson, DV
    Johnson, GK
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A355 - A355
  • [44] Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy
    Liao, Xueling
    Xiao, Yanan
    Elbelt, Ulf
    Weylandt, Karsten H.
    Li, Kanghui
    Deng, Jie
    Zeng, Ning
    Xue, Chao
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [45] Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males
    Ovaskainen, Yrjoe
    Koponen, Hannu
    Jokelainen, Jari
    Keinaenen-Kiukaannniemi, Sirkka
    Kumpusalo, Esko
    Vanhala, Mauno
    PSYCHIATRY RESEARCH, 2009, 167 (1-2) : 73 - 79
  • [46] Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils
    Langereis, J. D.
    Oudijk, E-J. D.
    Schweizer, R. C.
    Lammers, J-W. J.
    Koenderman, L.
    Ulfman, L. H.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 406 - 415
  • [47] COMPARATIVE RESPONSES OF HUMAN AND RABBIT INTERLEUKIN-1 INVIVO - EFFECT OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST
    VONUEXKULL, C
    NOURSHARGH, S
    WILLIAMS, TJ
    IMMUNOLOGY, 1992, 77 (04) : 483 - 487
  • [48] GROWTH MODULATION OF HUMAN PROSTATIC-CANCER CELLS BY INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    HSIEH, TC
    CHIAO, JW
    CANCER LETTERS, 1995, 95 (1-2) : 119 - 123
  • [49] Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice
    Chen, A
    Sheu, LF
    Chou, WY
    Tsai, SC
    Chang, DM
    Liang, SC
    Lin, FG
    Lee, WH
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) : 693 - 702
  • [50] Decreased levels of peritoneal interleukin-1 receptor antagonist in patients with endometriosis and disease-related dysmenorrhea
    Xinmei Zhang
    Jie Wen
    Lin Deng
    Jun Lin
    FERTILITY AND STERILITY, 2007, 88 (03) : 594 - 599